Business

Evernorth Health Services Announces Investment in Shields Health Solutions

Evernorth Health Services ("Evernorth"), a subsidiary of The Cigna Group (NYSE: CI), today announced a $3.5 billion investment in Shields Health Solutions ("Shields" or the "Company"), a leading specialty pharmacy management company. Evernorth's investment coincides with Shields' establishment as a private standalone company upon its acquisition by Sycamore Partners ("Sycamore"), a leading private equity firm based in New York. This follows Sycamore's acquisition of Walgreens Boots Alliance ("WB

articleThe Cigna GroupSeptember 2, 20258/company/cigna-corp/news/evernorth-health-services-announces-investment-in-shields-health-solutions
Evernorth Health Services Announces Investment in Shields Health Solutions

About this update from The Cigna Group

[{"type":"text","content":"Investment Further Enhances Evernorth's Participation in Growing Market for Specialty Medicine ","length":103,"tagName":"p","attribs":{}},{"type":"text","content":"BLOOMFIELD, Conn., Sept. 2, 2025 /PRNewswire/ -- Evernorth Health Services ("Evernorth"), a subsidiary of The Cigna Group (NYSE: CI), today announced a $3.5 billion investment in Shields Health Solutions ("Shields" or the "Company"), a leading specialty pharmacy management company. Evernorth's investment coincides with Shields' establishment as a private standalone company upon its acquisition by Sycamore Partners ("Sycamore"), a leading private equity firm based in New York. This follows Sycamore's acquisition of Walgreens Boots Alliance ("WBA"), Shields' previous owner, which closed on August 28, 2025. Evernorth's investment in Shields is in the form of preferred stock and is not expected to have a material impact to The Cigna Group's previously issued 2025 adjusted EPS guidance of at least $29.60.","length":885,"tagName":"p"},{"type":"image","alt":"Evernorth Health Services (PRNewsfoto/Evernorth Health Services)","displaySize":"","headline":null,"caption":"Evernorth Health Services (PRNewsfoto/Evernorth Health Services)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":132,"url":"https://media.zenfs.com/en/prnewswire.com/f5888fd54d1340eedeeec53f65ae0bf1"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/M5c928wEkll1fYRmpkX9Yg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTIzMztjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/f5888fd54d1340eedeeec53f65ae0bf1","width":400,"height":132}},"href":"https://mma.prnewswire.com/media/2090139/Evernorth_Health_Services_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":""Demand for specialty medications continues to grow at an accelerated pace, and Evernorth is uniquely positioned to serve the rapidly expanding number of individuals living with complex and chronic conditions and the doctors who care for them," said David M. Cordani, Chairman and Chief Executive Officer, The Cigna Group. "Investing in Shields aligns with our commitment to delivering exceptional care across health care settings – from home to physician's office or clinic, to hospital."","length":513...

More updates from The Cigna Group

Sycamore PartnersThe Cigna Groupspecialty pharmaciesCigna GroupShieldsForward-Looking Statementshealth systemsspecialty pharmacyShieldsEvernorth